Combined exercise training in men with metabolic syndrome after acute coronary event
Authors:
H. Svačinová 1; V. Mrkvicová 1; J. Pochmonová 1; B. Rosenbergová 1; J. Siegelová 1; P. Dobšák 1; J. Vítovec 2
Authors place of work:
Klinika tělovýchovného lékařství a rehabilitace Lékařské fakulty MU a FN u sv. Anny v Brně, přednosta prof. MUDr. Petr. Dobšák, CSc.
1; I. interní kardio-angiologická klinika Lékařské fakulty MU a FN u sv. Anny v Brně, přednosta prof. MUDr. Jiří Vítovec, CSc., FESC
2
Published in the journal:
Vnitř Lék 2011; 57(9): 764-771
Category:
65th birthday Mudr. Jany Laciné and and 60th birthday Milana Tržila
Summary
Introduction:
Favourable effect of exercise training on cardiovascular prognosis in patients with metabolic syndrome have been documented in lot of studies. Less information exist about results of cardiovascular rehabilitation in patients with different forms of coronary heart disease and associated diseases and abnormalities within metabolic syndrome. Methods: The present article evaluates a benefit of combined, aerobic-resistance training in two groups of patients after percutaneous coronary intervention for acute coronary syndrome: with [group MS(+), n = 42] and without [group MS(–), n = 53] metabolic syndrome. The changes in aerobic capacity (VO2peak, VO2peak . kg–1), physical performance (Wpeak, Wpeak . kg–1), blood pressure, BMI and waist circumference after 12 weeks of cardiovascular rehabilitation are evaluated. Results: Significant improvement in aerobic capacity and physical performance were found out both in group MS(+) and MS(–) (p < 0.01, resp. p < 0.001). Decrease of systolic blood pressure was significant in MS(+), whereas in MS(–) together with decrease of diastolic BP in both groups were not significant. The increase in aerobic capacity and physical performance in patients of MS(+) is comparable with those in MS(–); the decrease in systolic BP was more intensive in MS(+) compared to MS(–). The changes in waist circumference and BMI were not significant in both groups. Conclusion: The results show, that in patients with high number of risk factors associated with metabolic syndrome was demonstrated at least comparable benefit from cardiovascular rehabilitation compared with those without metabolic syndrome.
Key words:
metabolic syndrome – acute coronary event – cardiovascular rehabilitation – aerobic capacity
Zdroje
1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607
2. Zuanetti G, Latini R, Maggioni AP et al. Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol 1993; 22: 1788–1794.
3. Behar S, Boyko V, Reicher-Reiss H et al. Ten-year survival after acute myocardial infarction: comparison of patients with and without diabetes. SPRINT Study Group. Secondary Prevention Reinfarction Izraeli Nifedipine Trial. Am Heart J 1997; 133: 290–296.
4. Vaccaro O, Berly LE, Neaton JD et al. Multiple Risk Factor Intervention Trial Research Group. Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial. Arch Intern Med 2004; 164: 1438–1443.
5. Otter W, Kleybrink S, Doering W et al. Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus. Diabet Med 2004; 21: 183–187.
6. Howard BV, Best LG, Galloway JM et al. Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care 2006; 29: 391–397.
7. Oldridge NB, Guyatt GH, Fischer ME et al. Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. JAMA 1998; 260: 945–995.
8. O’Connor GT, Buring JE, Yusuf S et al. An Overview of Randomized Trials of Rehabilitation With Exercise After Myocardial Infarction. Circulation 1989; 80: 234–244.
9. Yoshida T, Yoshida K, Yamamoto C et al. Effects of Two-Week, Hospitalized Phase II Cardiac Rehabilitation Program on Physical Capacity, Lipid Profiles and Psychological Variables in Patients With Acute Myocardial Infarction. Jpn Circ J 2001; 65: 87–93.
10. Taylor RS, Brown A, Ebrahim S et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 2004; 116: 682–692.
11. Milani RV, Lavie CJ. Prevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyle change with cardiac rehabilitation. Am J Cardiol 2003; 92: 50–54.
12. Banzer JA, Maguire TE, Kennedy CM et al. Results of cardiac rehabilitation in patients with diabetes mellitus. Am J Cardiol 2004; 93: 81–84.
13. Vèrges B, Cohen M, Lucas B et al. Effects of cardiac rehabilitation on exercise capacity in Type 2 diabetic patients with coronary artery disease. Diabet Med 2004; 21: 889–895.
14. Lavie CJ, Milani RV. Cardiac rehabilitation and exercise training programs in metabolic syndrome and diabetes. J Cardiopulm Rehabil 2005; 25: 59–66.
15. Hindman L, Falko JM, Laponde M et al. Clinical profile and outcomes of diabetic and nondiabetic patients in cardiac rehabilitation. Am Heart J 2005; 150: 1046–1051.
16. Chaloupka V, Siegelová J, Špinarová L et al. Rehabilitace u nemocných s kardiovaskulárním onemocněním. Cor Vasa 2006; 48: K127–K145.
17. Grundy SM, Cleeman JI, Daniels SR et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation 2005; 112: 2735–2752.
18. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356–359.
19. Cífková R. Epidemiologie metabolického syndromu ve světě a v České republice. Předneseno na Sympoziu o syndromu inzulinové rezistence. Praha 26.–27. února 2003
20. Savage PD, Banzer JA, Balady GJ et al. Prevalence of metabolic syndrome in cardiac rehabilitation/secondary prevention programs. Am Heart J 2005; 149: 627–631.
21. Takeno M, Yasuda S, Otsuka Y et al. Impact of metabolic syndrome on the long-term survival of patients with acute myocardial infarction: potential association with C-reactive protein. Circ J 2008; 72: 415–419.
22. Cífková R, Skodová Z, Bruthans J et al. Longitudinal trends in cardiovascular mortality and blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2007/2008. J Hypertens 2010; 28: 2196–2203.
23. Wannamethee SG, Shaper AG, Walker M. Changes in physical activity, mortality and incidence of coronary heart disease in older men. Lancet 1998; 30: 1603–1608.
24. Haapanen N, Miilunpalo S, Vuori OPet al. Association of leisure time physical activity with the risk of coronary heart disease, hypertension and diabetes in middle-aged men and women. Int J Epidemiol 1998; 27: 335–336.
25. Laaksonen DE, Lakka HM, Salonen JT et al. Low Levels of Leisure-Time Physical Activity and Cardiorespiratory Fitness predict development of the Metabolic Syndrome. Diabetes Care 2002; 25: 1612–1618.
26. Lakka TA, Laaksonen DE, Lakk HM et al. Sedentary Life Style, Poor Cardiorespiratory Fitness, and the Metabolic Syndrome. Med Sci Sports Exerc 2003; 35: 1279–1286.
27. Whaley MH, Kampert JB, Kohl HV 3rd et al. Physical fitness and clustering of risk factors associated with the metabolic syndrome. Med Sci Sports Exerc 1999; 31: 287–293.
28. Lee CD, Blair SN, Jackson AS. Cardiorespiratory fitness, body composition, and all cause and cardiovascular disease mortality in men. Am J Clin Nutr 1999; 69: 373–380.
29. Shubair MM, Kodis J, McKelvie RS et al. Metabolic profile and exercise capacity outcomes: their relationship to overweight and obesity in a Canadian cardiac rehabilitation setting. J Cardiopulm Rehabil 2004; 24: 405–413.
30. Svačinová H, Nováková M, Placheta Z et al. Benefit of Combined Cardiac Rehabilitation on Exercise Capacity and Cardiovascular Parameters in Patients with Type 2 Diabetes. Tohoku J Exp Med 2008; 215: 103–111.
31. Suresh V, Harrison RA, Houghton P et al. Standard cardiac rehabilitation is less effective for diabetics. Int J Clin Pract 2001; 55: 445–448.
32. Kavanagh T, Mertens DJ, Hamm LF et al. Prediction of long-term prognosis in 12 169 men referred for cardiac rehabilitation. Circulation 2002; 106: 666–671.
33. Myers J, Prakash M, Froelicher V et al. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002; 346: 793–801.
34. Keteyian SJ, Brawner CA, Savage PD et al. Peak aerobic capacity predicts prognosis in patients with coronary heart disease. Am Heart J 2008; 156: 292–300.
35. Bader DS, Maguire TE, Spahn CM et al. Clinical profile and outcomes of obese patients in cardiac rehabilitation stratified according to National Heart, Lung, and Blood Institute criteria. J Cardiopulm Rehabil 2001; 21: 210–217.
36. Gayda M, Brun C, Juneau M et al. Long-term cardiac rehabilitation and exercise training programs improve metabolic parameters in metabolic syndrome patients with and without coronary heart disease. Nutr Metab Cardiovasc Dis 2008; 18: 142–151.
37. Romero-Corral A, Montori VM, Somers VK et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006; 368: 666–678.
38. Sierrra-Johnson J, Romero-Corral A, Somers VK et al. Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index. Eur J Cardiovasc Prev Rehabil 2008; 15: 336–340.
39. Abdulla J, Køber L, Abildstrøm SZ et al. Impact of obesity as a mortality predictor in high-risk patients with myocardial infarction or chronic heart failure: a pooled analysis of five registries. Eur Heart J 2008; 29: 594–601.
Štítky
Diabetology Endocrinology Internal medicineČlánok vyšiel v časopise
Internal Medicine
2011 Číslo 9
Najčítanejšie v tomto čísle
- Proteinuria in primary care
- Prokinetic agents – their contribution to practice of gastroenterology
- Plypharmacy and drug interactions
- Thyreopathy in primary care